...
首页> 外文期刊>International Journal of Pharmaceutics >Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: A potential candidate for overcoming multi-drug resistance
【24h】

Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: A potential candidate for overcoming multi-drug resistance

机译:涂有聚乙二醇化透明质酸的阳离子脂质体的抗P糖蛋白siRNA的基因传递效率提高:克服多药耐药性的潜在候选人

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

RNA interference is an effective method to achieve highly specific gene regulation. However, the commonly used cationic liposomes have poor biocompatibility, which may lead to systematic siRNA delivery of no avail. PEGylation is a good strategy in shielding the positive charge of cationic liposomes, but the enhanced serum stability is often in company with compromised cellular uptake and endosome escape. In this study, PEG was covalently linked to negatively charged hyaluronic acid and it was used to coat the liposome-siRNA nanoparticles. The resulting PEG-HA-NP complex had a diameter of 188.6 +/- 10.8 nm and a dramatically declined zeta-potential from +34.9 +/- 4.0 mV to -18.2 +/- 2.2 mV. Owing to the reversed surface charge, PEG-HA-NP could remain stable in fetal bovine serum (FBS) to up to 24 h. In contrast with normal PEGylation, hyaluronic acid and PEG co-modified PEG-HA-NP provided comparable cellular uptake and P-glycoprotein downregulation efficacy in MCF-7/ADR cells compared with Lipofectamine RNAiMAX and naked NP regardless of its anionic charged surface. Because of its good biocompatibility in serum, PEG-HA-NP possessed the best tumor accumulation, cellular uptake and subsequently the strongest P-glycoprotein silencing capability in tumor bearing mice compared with naked NP and HA-NP after i.v. injection, with a 34% P-glycoprotein downregulation. Therefore, PEG-HA coated liposomal complex was demonstrated to be a promising siRNA delivery system in adjusting solid tumor P-glycoprotein expression, which may become a potential carrier in reversing MDR for breast cancer therapy. (C) 2014 Elsevier B.V. All rights reserved.
机译:RNA干扰是实现高度特异性基因调控的有效方法。然而,常用的阳离子脂质体具有较差的生物相容性,这可能导致系统的siRNA传递无效。聚乙二醇化是屏蔽阳离子脂质体正电荷的良好策略,但增强的血清稳定性通常伴随着细胞摄取和内体逃逸的减弱。在这项研究中,PEG与带负电荷的透明质酸共价连接,并被用于包覆脂质体-siRNA纳米颗粒。所得的PEG-HA-NP复合物的直径为188.6 +/- 10.8nm,并且ζ电位从+34.9 +/- 4.0mV急剧下降至-18.2 +/- 2.2mV。由于表面电荷的反转,PEG-HA-NP在胎牛血清(FBS)中可以保持稳定长达24小时。与正常的PEG化相比,透明质酸和PEG共修饰的PEG-HA-NP与Lipofectamine RNAiMAX和裸露NP相比,无论其带负电荷的表面如何,在MCF-7 / ADR细胞中均可提供相当的细胞摄取和P-糖蛋白下调功效。由于其在血清中具有良好的生物相容性,因此与裸露的NP和HA-NP相比,PEG-HA-NP在荷瘤小鼠中具有最佳的肿瘤蓄积,细胞摄取以及随后最强的P-糖蛋白沉默能力。注射,P-糖蛋白下调34%。因此,PEG-HA包被的脂质体复合物被证明是一种有前景的siRNA传递系统,可用于调节实体肿瘤P-糖蛋白的表达,这可能成为逆转MDR乳腺癌治疗的潜在载体。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号